Indivumed Services, a Crown Bioscience Company, is a global contract research organization (CRO) that offers an industry-leading oncology biobank and a range of service platforms to advance oncology and immuno-oncology drug discovery and development. Holding a unique biobank of clinical specimens, unrivalled in quality and associated clinical history, which currently totals almost one million patient samples, the company partners with extensive clinical network of more than 60 entities in the United States, Europe, and Asia providing direct and controlled access to relevant surgical biospecimens and blood samples. Further known for their enhanced immunohistochemistry and spatial transcriptomics, Indivumed Services’ platforms complement a range of established Crown Bioscience capabilities supporting biomarker discovery. Imprint: https://www.indivumedservices.com/imprint